Results 91 to 100 of about 81,928 (305)

Beyond the numbers: Critical analysis of the role of postmortem tryptase in the forensic diagnosis of anaphylaxis

open access: yesJournal of Forensic Sciences, EarlyView.
Abstract The postmortem diagnosis of anaphylaxis remains a forensic challenge due to the lack of specific external signs. Tryptase, a mast cell‐derived protease, has emerged as a potential biomarker for fatal anaphylaxis. This systematic review critically examined 40 studies published between 2014 and 2024, including both biochemical and ...
Luca Tomassini   +8 more
wiley   +1 more source

Melanoma and Mastocytosis

open access: yesOpen Access Macedonian Journal of Medical Sciences, 2019
There are numerous cases reports and studies confirming the enhanced incidence of melanoma among patients with mastocytosis, especially with systemic mastocytosis. These two diseases are arising from two different types of cells; melanoma arises from neural crest cells and mastocytosis from hematopoietic stem cells.
Aleksandra Vojvodic   +13 more
openaire   +3 more sources

Mastocitosis cutánea maculopapular infantil: reporte de un caso

open access: yesRevista Médica Clínica Las Condes, 2019
Resumen: Objetivo: Reportar un caso de mastocitosis cutánea maculopapular de inicio en la infancia y realizar una revisión bibliográfica con énfasis en el diagnóstico, estudio, pronóstico y tratamiento.
Renatta de Grazia   +3 more
doaj   +1 more source

Case-control cohort study of patients' perceptions of disability in mastocytosis. [PDF]

open access: yesPLoS ONE, 2008
BackgroundIndolent forms of mastocytosis account for more than 90% of all cases, but the types and type and severity of symptoms and their impact on the quality of life have not been well studied.
Olivier Hermine   +20 more
doaj   +1 more source

Human Skin/SCID Mouse Chimeras as an In Vivo Model for Human Cutaneous Mast Cell Hyperplasia [PDF]

open access: yes, 1997
Human skin xenografted to mice with severe combined immunodeficiency syndrome (SCID) was evaluated to determine the integrity and fate of human dermal mast cells.
Melpo Christofidou-Solomidou   +42 more
core   +1 more source

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis [PDF]

open access: yes, 2016
We evaluated the impact of clinical and molecular characteristics on overall survival (OS) in 108 patients with indolent (n=41) and advanced SM (advSM, n=67).
Clemens, J.   +14 more
core   +1 more source

Mastocitosis

open access: yesRevista Alergia México, 2015
Mastocytosis is one of the eight subcategories of the myeloproliferative neoplasms of the classification of lymphoid and hematopoietic tissues’ tumors of 2008 of World Health Organization; it is an heterogeneous group of myeloproliferative diseases characterized by the excessive proliferation of atypical mastocytes in morphological and immunophenotype ...
González Díaz, Sandra Nora   +3 more
openaire   +3 more sources

Cutaneous Mastocytosis in Children: Is It Just a Skin Disease?

open access: yesÇocuk Dergisi, 2021
Introduction: Mastocytosis is characterized by the excessive proliferation and accumulation of mast cells in organs such as the spleen, liver, lymph nodes, skin, gastrointestinal tract, and bone marrow.
Tuğba Aktürk   +2 more
doaj   +1 more source

Prolonged IL‐33 Exposure Switches the Secreted Mast Cell Cytokine Profile From Pro‐Inflammatory to Pro‐Tolerant

open access: yesAllergy, EarlyView.
This study investigates the effect of IL‐33 and Hymenoptera venom on mast cell cytokine profiles under venom immunotherapy (VIT)‐like conditions. Our in vitro model of VIT‐like mast cell stimulation demonstrates a modulatory effect of IL‐33 on the secreted mast cell cytokine profile.
Andrea R. Teufelberger   +3 more
wiley   +1 more source

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2020
In indolent systemic mastocytosis (ISM), several risk factors of disease progression have been identified. Previous studies, performed with limited patient numbers, have also shown that the clinical course in ISM is stable and comparable to that of ...
J. Trizuljak   +42 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy